FDA Approved: ETOMIDATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Etomidate from Hikma Pharmaceuticals USA Inc. under ANDA 202354.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• General Anesthesia

Drugs mentioned

• Etomidate (etomidate)

Snippet

SUPPL AP for ETOMIDATE (ETOMIDATE)